InsidersTradesSigma
Follow the GSS stock price and the full management transaction log of the company, a publicly traded company based in Australia. Shares are listed on the AU market, under the authority of ASX. Operating in the Health Care sector, GSS has logged 4 insider filings. Market capitalisation: €13.2m. The latest transaction was reported on 2 July 2026 (Initial Substantial Holding). Among the most active insiders: BCAL DIAGNOSTICS LIMITED. Every trade is accessible without an account.
4
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 20,135 of 28,833 companies
38.5
score / 100
Value33
Quality44
FCF yld-58%
Earn yld4.6%
EV/EBITDA·
ROE3.8%
Gross mgn49%
Net mgn0.1%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 2 July 2026
Declarations4 total
ShareASXASX:2924-03107151-2A1681941
ShareASXASX:2924-03088041-2A1671113
4 of 4 declarations
About GSS
GSS is a company operating in the health and pharmaceutical sector. It is listed on the XASX market.